Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-PD-L1&TGFBR2, M7824 Vector   (CAT#: GTVCR-WQ1813MR)

This product GTVCR-WQ1813MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting PD-L1; TGFBR2. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001267706.2; NM_001024847.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 29126; 7048
UniProt ID Q9NZQ7; P37173
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-PD-L1&TGFBR2, M7824 Vector (GTVCR-WQ1813MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ338MR IVTScrip™ pSP6-VEE-mRNA-Anti-SLITRK6, AGS-15E Vector Vector AGS-15E
GTVCR-WQ1880MR IVTScrip™ pT7-VEE-mRNA-Anti-pcrV&psl, MEDI3902 Vector Vector MEDI3902
GTVCR-WQ1239MR IVTScrip™ pT7-VEE-mRNA-Anti-MS4A1, GA101 Vector Vector GA101
GTVCR-WQ591MR IVTScrip™ pT7-VEE-mRNA-Anti-APP, BAN-2401 Vector Vector BAN-2401
GTVCR-WQ160MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, ABBV-221 Vector Vector ABBV-221
GTVCR-WQ991MR IVTScrip™ pT7-VEE-mRNA-Anti-IL31RA, CIM 331 Vector Vector CIM 331
GTVCR-WQ31MR IVTScrip™ pT7-VEE-mRNA-Anti-CA9, 124I_WX-G250 Vector Vector 124I_WX-G250
GTVCR-WQ1400MR IVTScrip™ pT7-VEE-mRNA-Anti-MUC1, hPAM4 Vector Vector hPAM4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.